Denmark defends controversial Covid-19 pill

The tablet treatment against Covid-19 can prevent hospitalizations, says Danish Health Authority Director General Søren Brostrøm. He maintains it was the right decision to allow the use of the unapproved pill.

Søren Brostrøm, Director General at the Danish Health Authority | Photo: Philip Davali

The Danish Health Authority is defending the use of the heavily criticized Covid-19 pill, Lagevrio (molnupiravir), which is meant to prevent serious infections.

Denmark has bought around 50,000 pills from pharmaceutical firm MSD so far. A purchase that has proven controversial, as practicing doctors have questioned the treatment's efficacy.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs